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Runaway multi-allelic copy number 
variation at the α-defensin locus in 
African and Asian populations
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Jorunn S. Bringsli4,5, Anja torsvik4,5, Elin inderhaug1,2, Vidar M. Steen4,5 & Srdjan Djurovic1,4
Alpha defensins are anti-microbial peptides of the innate immune system. The defensin A1 and A3 
genes are located in a repeat array of variable copy number (the DEFA1A3 locus) and encode the 
human neutrophil peptides 1, 2 and 3. The possibility that copy number variation (CNV) may be 
associated with infection susceptibility and autoimmune pathology motivated the study of DEFA1A3 
CNV across populations. We enhanced two existing methods (one qPCR-based and one sequencing-
based) to enable copy number estimation that discriminates between DEFA1 and DEFA3 genes. We 
used these methods to quantify A1/A3 copy number variation in 2504 samples from the 1000 Genomes 
high-coverage dataset as well as performing fiberfiSH assays on selected samples to visualize the 
haplotypes. These methods produce accurate estimates and show that there are substantial differences 
between populations. The African population is a clear outlier with a high frequency of the ancestral 
pure DEFA1 haplotype, but also harbours exceptionally long haplotypes of 24 copies of both DEFA1 
and DEFA3, whilst the East Asian population displays the highest mean level of DEFA3 copy number. 
Further, our findings demonstrate that qPCR can be an accurate method for CNV estimation and that 
defensins substantially extend the known range of copy number variation for a human protein-coding 
gene.
The neutrophil is the most abundant granulocyte in human blood and is a central component of the innate 
immune system. Its granules are loaded with proteins with potent anti-microbial properties1 and the most abun-
dant among these are the three highly similar human neutrophil peptides (HNP1-3) which locate to azurophilic 
(or primary) granules where they comprise 30–50% of granule protein and 5–7% of total cellular protein2. During 
phagocytosis of a target microorganism, the primary granules fuse with phagocytic vacuoles in which they gen-
erate high concentrations of these alpha defensins1. Defensin hexamers then form pores in the pathogen’s cell 
membrane leading to permeabilization and cell death3,4.
In the human genome, the nucleotide sequence for the HNP proteins is found in the alpha defensin gene 
cluster on chromosome 8 (Fig. 1). DEFA1-3 (HNP1-3) and DEFA4 are expressed in neutrophils whilst DEFA5 
and DEFA6 are expressed in Paneth cells. HNP1 and HNP3 proteins differ from each other at a single amino 
acid whilst no gene has been discovered for the shorter HNP2. It is therefore thought that HNP2 is a proteolytic 
product of one or both of HNP1 and HNP35. DEFA1 and DEFA3 have long been known to be copy number 
variant6 whilst DEFA4 is only subject to deletion (and not duplication) in the samples from the 1000 genome 
(G1K) project (Fig. 1). DEFA1 has been in a multi-copy array for 25 million years (whilst DEFA3 is thought to be 
a human specific variant) and both genes differ in number and location within the array5. Thus, the two genes are 
viewed as variant repeats in gene array haplotypes and the gene locus is designated as DEFA1A3 by the HUGO 
Gene Nomenclature Committee.
Most European individuals have 5 or more DEFA1A3 copies per diploid genome7. On a general basis and as 
one would expect, it has been shown that individuals with high copy number of a gene, express it at a higher level 
than those with lower copy number8. Although this correlation was not observed for DEFA1A3 in a sample of 
111 normal individuals5, it is thought that the innate immune system’s need to rapidly produce large quantities of 
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DEFA1A3 peptides in response to infection probably confers a substantial fitness advantage to individuals with 
multiple copies of the gene and drives positive selection of gene duplications.
Gene copy number variation (CNV) is a well-known cause of rare genomic disorders, such as several recur-
rent microdeletions and microduplications that are associated with various neuropsychiatric phenotypes9,10. In 
those cases, the disease mechanism is usually related to the loss or gain of a single copy of the relevant gene(s). 
Variation in gene copy number can also contribute to more common human diseases such as psoriasis11 and 
asthma8,12. Further the relationship between copy number and pathology can be complex, as in the case of the 
complement C4 gene, where low copy number is associated with susceptibility to systemic lupus erythematosus, 
whilst high copy number is associated with schizophrenia13,14. Some gene-based CNVs show particularly large 
variation within and between populations, such as the amylase gene AMY1, which may be present in 2 to 18 
copies per diploid genome15,16. In the specific case of DEFA1A3, low alpha-defensin gene copy number has been 
shown to increase the risk of IgA nephropathy and renal dysfunction17, whilst increased α-defensins levels have 
been shown to be a marker for schizophrenia susceptibility18 and to be associated with susceptibility to severe 
sepsis19,20.
Interestingly, this type of genetic variation is often overlooked due to the technical challenge of accurate copy 
number measurement and this has been proposed as one of the possible causes of the missing heritability paradox 
of many common disorders21. Due to the high similarity between DEFA1 and DEFA3, specific measurement of 
their gene copy number is non-trivial and several different approaches for DEFA1A3 CNV analysis have been 
published5,7,22.
In the present study, we set out to refine existing methods for the measurement of DEFA1 and DEFA3 gene 
copy number - one based on high throughput sequencing (HTS) and one based on quantitative polymerase chain 
reaction (qPCR). We then used these methods to generate a comprehensive and accurate overview of DEFA1A3 
copy number variation (including the A1/A3 ratio) in a wide range of human populations. Interestingly, our 
detailed study of this specific locus also led us to interesting general observations with regards to the estimation 
and the extent of copy number variation in the human genome.
Results
Estimating DEFA1 and DEFA3 copy number using HTS data. We accessed whole genome sequenc-
ing data for 2,504 samples of different ethnicities (AFR 661, AMR 347, EAS 504, EUR 503, SAS 489) from the 
high-coverage phase 3 of the 1000 Genomes (G1K) project and downloaded all reads that mapped to the α-defen-
sin locus (Fig. 1). We estimated DEFA1A3 copy number with GenomeSTRiP and used the allelic ratio for reads 
covering the sequence difference between DEFA1 and DEFA3 to calculate the gene copy numbers (CN) per dip-
loid genome in each sample. The mean CN across all super-populations is 5.7 for DEFA1 and 1.4 for DEFA3 and 
all super-populations have means approximately equal to these numbers (Table 1). However, these mean statistics 
conceal important differences in DEFA1A3 CN distribution between populations, especially regarding DEFA3.
First, and most strikingly, individual HG02554 of African-Caribbean ethnicity carries 26 copies of DEFA1A3 
(15 DEFA1 and 11 DEFA3, Fig. 2A). Second, the African super-population differs substantially from the other 
super-populations in that approximately a third of African samples have genotypes with no DEFA3 copies 
(Table 1 and Fig. 2B), but the samples with the highest DEFA3 copy numbers are also African (Figs. 2A and S2B). 
We investigated whether the samples with high DEFA3 CN may be due to unreliable estimates of the DEFA3 
fraction, but this does not appear to be the case (Fig. S3). We also investigated whether the high DEFA3 CN in 
Africans may be limited to specific populations, but we found that all 7 African populations have individuals with 
high DEFA3 CN (Fig. S4). Third, the Asian super-population has high numbers of samples with more than 10 
copies of DEFA1 (Figs. 2 and S2A). These are primarily Japanese samples (Fig. S5).
Figure 1. Overview of the defensin-α locus and HTS DEFA1/DEFA3 ratio estimation. Genes in black and 
pseudogenes in grey. WG: whole genome sequencing. GenomeStrip CNV regions are the regions defined in 
Handsaker et al.8 which do not capture the true nature of the underlying DEFA1A3 repeat.
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We can also use the genotypes to make inferences about haplotype structure. We observe many samples with 
pure DEFA1 genotypes with CN ranging from 3 to 16 implying that pure DEFA1 haplotypes as short as 1 CN 
and as long as 8 CN exist. We do not observe any samples with a pure DEFA3 genotype which suggests that pure 
DEFA3 haplotypes are either very rare or non-existent (Fig. 2).
Visualization and characterization of the DEFA1A3 haplotypes. We produced a fully independent 
validation of our HTS-based DEFA1A3 CN estimates by performing FiberFISH analysis of four selected samples 
with high DEFA1A3 CN values. The fluorescent probes that hybridise to different parts of the alpha-defensin 
locus (Fig. 1) disclose the haplotype structure in detail (Fig. 3). The genotype of individual HG02554 is highly 
surprising because its exceptional DEFA1A3 CN of 26 is not the result of a duplication of the whole repeat array, 
but rather consists of the extremes of haplotype size with one huge haplotype of 24 CN and one small haplotype 
of 2 CN (Fig. 3, row 1). It is also evident that genotypes with 15 and 16 DEFA1A3 CN consist of different combi-
nations of haplotypes: 8 + 8, 9 + 7, and 11 + 4 (Fig. 1, rows 2 to 4).
The HTS data can also be used to shed a broader light on the issue of whole locus duplication by plotting 
DEFA1A3 CN vs DEFT1P CN for all 2504 samples (Fig. S6). We observe that DEFA1A3 CN = DEFT1P CN + 2, 
i.e. that there are always two partial repeats (lacking DEFT1P) in each genome (Fig. 1). A higher discrepancy 
would be indicative of more than 2 partial repeats per genome suggesting a duplication of the locus. There is no 
tendency for samples with high DEFA1A3 CN to have a greater difference between DEFA1A3 CN and DEFT1P 
CN suggesting that, as for HG02554, high CN genotypes are the result of DEFA1A3 haplotypes with a single high 
CN defensin locus rather than duplication of the whole locus.
Independent verification of HTS copy number estimates by qPCR. The FiberFISH method pro-
vides exact quantification of copy number and reveals the haplotypes, but it is an expensive and time-consuming 
method that cannot be easily applied to many samples and it does not provide an estimate of the DEFA1/DEFA3 
CN ratio. We therefore analysed 69 G1K samples to check the quality of our HTS CN estimates with an orthogo-
nal method (Fig. 4). We generally found a very high correlation between our HTS estimate and the qPCR estimate 
with all correlations exceeding 96% and the vast majority of estimates deviating from each other by less than 1 
CN. The variance of the estimates did not increase as CN increased. Finally, we also checked the consistency 
Super-
population
DEFA1 DEFA3 DEFA3 Absence 
(%)Min Max Mean Min Max Mean
EUR 0.8 11.6 5.7 0 4.4 1.4 13.1
AFR 0.9 14.5 5.7 0 10.8 1.5 28.7
EAS 0.7 16.1 6.1 0 5.1 1.5 11.5
AMR 0.6 10.3 5.2 0 4.5 1.4 12.7
SAS 1.0 11.1 5.6 0 5.3 1.3 11.2
ALL 0.6 16.1 5.7 0 10.8 1.4 16.3
Table 1. DEFA1 and DEFA3 copy number distribution statistics by super-population. The DEFA3 absence 
number is the percent of genotypes in the population with zero copies of DEFA3.
Figure 2. HTS copy number estimates by super-population. (A) DEFA1 and DEFA3 copy number for all 
samples (light grey lines delineate genotypes with total CN of 5, 10, and 15). (B) 2D densities for each super-
population. For both (A,B): AFR African (black), EUR European (blue), EAS East Asian (gold), SAS South 
Asian (green), AMR ad mixed American (red).
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Figure 3. Haplotypes by FiberFISH annotated with DEFA1A3 copy number. Probe colours as defined in 
Fig. 1: DEFA1A3 gene (red), DEFT1P pseudogene (green), left flank (red & blue), right flank (blue only). 
For HG02554, qPCR estimates match FiberFISH estimates exactly as this FiberFISH sample was used for 
calibration/scaling of the qPCR estimates.
Figure 4. Concordance of HTS and qPCR copy number genotyping methods. (A). DEFA1, (B). DEFA3, (C). 
DEFA1A3, (D). DEFA1A3 vs DEFA1 + DEFA3 (both by qPCR). ρ: Pearson correlation coefficient. Solid line: 
y = x. Thin lines: y = x + 1 and y = x-1.
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of qPCR with itself by comparing DEFA1A3 CN with the sum of the two separate DEFA1 CN and DEFA3 CN 
assays (Fig. 4D). We found a Pearson correlation of 96.9% and a slight tendency for DEFA1A3 to generate lower 
CN estimates than DEFA1 + DEFA3. This slight bias is most likely due to the qPCR scaling factors not being 
completely exact. We conclude that our HTS CN estimates are accurate in estimating both the total DEFA1A3 
CN and the DEFA1/A3 CN ratio and thus that they provide an accurate picture of DEFA1A3 genotype variation 
across populations.
In the exploratory phase of this work, we tested the qPCR amplifications on the Polymorphism Discovery 
Resource panel of 24 used by Linzmaier and Ganz22, but found that our qPCR DEFA1A3 CN estimates were 
substantially and consistently lower than those reported by them (an average discrepancy of 46%) despite the fact 
that we are using their original primers (Table S5). Given that we find high concordance between our qPCR and 
HTS estimates (Fig. 4) as well as high concordance between DEFA1A3 and DEFA1 + DEFA3 (both by qPCR), we 
conclude that the Ganz and Linzmaier primers can be used to provide good estimates of DEFA1 and DEFA3 CN, 
but that the copy numbers reported in their paper are inaccurate22. This is probably due to the fact that they do 
not apply a scaling factor to compensate for the differences in efficiency between target and endogenous control 
amplifications.
The DEFA1A3 locus in archaic humans. The HTS data from archaic humans clearly shows that the 
DEFA1A3 locus was copy number variant in the Denisova, Altai and Vindija samples (Fig. S8). Further, there 
is clear evidence of the presence of DEFA3 variation in the Altai and Vindija samples, but we do not observe the 
DEFA3 variation in the Denisova sample (Fig. S9). However, since this is a single sample, it is not possible to con-
clude whether the DEFA3 variation was present in Denisova population or not.
Discussion
DEFA1A3 copy numbers – Inter-individual variation. Copy number variation has been investigated 
genome-wide on large numbers of samples by the Wellcome Trust Case Control Consortium23 and in phase 1 of 
the G1K project8. Interestingly, in the WTCCC study, the DEFA1A3 CNV was not scored (perhaps due to strict 
quality control criteria of CNV typing), whilst in the G1K study, the CN distribution for DEFA1A3 was estimated 
to have a mean of approximately 5 (Fig. S7) whereas we estimate it to be 7.1 in the phase 3 data. The reason for this 
discrepancy is not the difference between phase 1 and 3, but the fact that the automatic method used to identify 
the basic unit of the CNV incorrectly identifies the partial repeat as part of the basic unit and leaves the left-most 
part of the full-repeat out (Fig. 1). As a result, these measurements underestimate the true copy number by 2 cop-
ies. This specific issue with DEFA1A3 highlights the importance but also the challenge of correctly identifying the 
basic unit of a CNV when estimating the copy number of a gene or genomic region. Other CNVs may be affected 
by a similar issue, in which case, current levels of copy number variation may be underestimated.
Previous work, focused specifically on the CNV at the DEFA1A3 locus, correctly estimated the mean CN5,7 
and identified the high fraction of African samples lacking DEFA324. However, the difference in distribution 
between populations and in particular the non-negligible frequency of DEFA1A3 CN genotypes with 12-16 in 
African and East Asian populations has not been previously reported (Fig. 2).
Sample HG02554 from an African Caribbean in Barbados with a genotype of 26 CN and haplotypes 24/2 
CN (Fig. 3) is an interesting curiosity as it is to our knowledge the longest repeat of a protein coding gene in the 
human genome. The largest estimated CNV genotype detected genome-wide in the phase 1 of G1K is 15 CN8, 
implying haplotypes that are most likely shorter. Thus, the defensin-α locus and this specific sample demonstrate 
that the maximal range of copy number variation for protein coding genes in the human genome is substantially 
greater than previously thought.
Enhanced DEFA1 and DEFA3 copy number genotyping. A number of techniques have been devel-
oped for genotyping DEFA1A3 copy number. Two methods were published almost simultaneously in 2005. 
Linzmaier and Ganz proposed using primers that were specific to DEFA1 and DEFA3 in qPCR reactions (Fig. 1)22, 
while Aldred, Hollox and Armour used multiplex amplifiable probe hybridization (MAPH) combined with 
restriction variant digest ratio assays5. Following the release of the G1K phase 1 whole genome data, Armour 
proposed using read coverage to estimate CN25, but in its basic form this method does not permit distinction of 
A1 and A3.
Our results build on and enhance these existing methods. First, we show that Linzmaier and Ganz primers 
provide good estimates of DEFA1 and DEFA3 CN, but that this requires a scaling factor to be applied to compen-
sate for the differences in efficiency between target and endogenous control amplifications. This qPCR method 
is simpler to perform than the MAPH-based method proposed by Aldred, particularly if one also requires the 
DEFA1/DEFA3 ratio. Interestingly, the higher mean DEFA1A3 CN obtained by Linzmaier relative to Aldred in 
European populations has been remarked upon7 and it was suggested that this may reflect limitations of real-time 
PCR typing for this locus. We find this to not be the case, as long as correct scaling is applied. This is an impor-
tant conclusion with regards to the use of qPCR in measuring copy number variation. Second, we propose an 
enhancement to Armour’s HTS-based read coverage estimate, where re-mapping of defensin-α reads to a refer-
ence consisting of a single copy of the DEFA1A3 gene enables accurate estimation of the A1/A3 ratio from the ref-
erence and alternative allele depths (Fig. 4). Thus, high throughput methods that enable discrimination between 
A1 and A3 are now available for analysing the growing number of samples that are whole genome sequenced or 
for genotyping new samples at the DEFA1A3 locus specifically.
Limitations. The primary limitation of this work is that the qPCR method produces a non-integer CN esti-
mate and we observe only mild clustering around integer copy numbers. Further, when we compare qPCR esti-
mates to either HTS estimates or FiberFISH exact copy numbers, although we observe good concordance between 
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methods with little bias (indicating that the methods are accurate), we see that the error margin is approximately 1 
CN (Figs. 3 and 4). As a result, we choose to report CN as a continuous variable rather than attempt to estimate an 
integer copy number. Use of droplet digital PCR would probably have improved the precision of our estimates and 
made them more amenable to providing an integer CN estimate, but this technology involves higher expense and 
reduced throughput. Further, it should be noted that the precision of CNV determination at copy number higher 
than 6 is limited even for droplet digital PCR methods (figure 4.1 in http://www.bio-rad.com/webroot/web/pdf/
lsr/literature/Bulletin_6407.pdf and Fig. 3 in8).
In this work, we use the FiberFISH copy number to scale our qPCR estimates which may be considered to 
limit the applicability of the method. However, it should be noted that G1K samples sequenced to very high depth 
(200X) are publicly available (https://www.illumina.com/platinumgenomes.html) and also provide an accurate 
scaling factor for the qPCR measurements (unpublished data).
evolution of the α-defensin gene locus. DEFA1 has been present in multiple copies since before the 
divergence of great apes from gibbons, but chimpanzee, bonobo, gorilla and orangutan all lack DEFA35. The 
whole genome sequence data from the Denisova, Altai and Vindija samples clearly show that these samples 
are copy number variant at the DEFA1A3 locus (Fig. S8) which was to be expected given the presence of the 
DEFA1A3 CNV in apes. Interestingly, the same data also show that the DEFA3 variation was present in the Altai 
and Vindija samples (Fig. S9). We used our enhanced HTS CN estimation to produce an overview of DEFA3 
frequency across populations. We observe that genotypes lacking DEFA3 are common in African populations 
whereas they are markedly less frequent in other populations (Fig. 2). However, genotypes containing DEFA3 are 
not rare in African populations and the samples with very high DEFA3 CN are all African (note that the 24 CN 
haplotype in HG02554 consists of at least 8 DEFA3 copies). Further, African samples carrying DEFA3 are found in 
all African populations at both low and high CN (Fig. S4). This data does not permit us to draw a firm conclusion 
on the origin of the DEFA3 variation. However, in the context of the debate surrounding the geographic origins 
of modern humans26–28, it is intriguing to observe that the DEFA3 mutation is present in archaic human remains 
found outside Africa and that modern non-African genotypes mostly contain copies of DEFA3, whereas approx-
imately one third of modern African genotypes lack a copy of DEFA3.
Materials and methods
Copy number estimation using whole genome sequencing data. We downloaded all whole 
genome sequencing reads mapping to the α-defensin locus (Fig. 1) for the 2504 high-coverage samples (AFR 661, 
AMR 347, EAS 504, EUR 503, SAS 489) from phase 3 of the 1000 genomes (G1K) project29 (http://ftp.1000ge-
nomes.ebi.ac.uk/vol1/ftp/data_collections/1000G_2504_high_coverage). We also accessed the pre-computed 
GenomeSTRiP8 metadata for these samples on Google Storage (gs://mccarroll-gs-1000g/md). We estimated 
DEFA1A3 and DEFT1 copy number for each sample by running GenomeSTRiP (svtoolkit_2.00.1949.tar.gz) with 
the GSMASKMODE set to MXINC as we found that it was consistent with the results from the default mask 
mode, but gave more clustering around integer values (full details in the supplementary materials). These are our 
high-throughput sequencing copy number estimates (HTS CN).
In order to estimate DEFA3 copy numbers, we first extracted all reads from genomic regions containing 
DEFA1A3 and then mapped them to the fasta sequence of the partial repeat (8:6872895-6876338) using the 
MEM algorithm of BWA30. We performed joint variant calling using GATK’s HaplotypeCaller at the SNP site that 
distinguishes DEFA1 from DEFA331. This is position 6,873,603 in HG19 or position 709 in our reference sequence 
for the partial repeat. For each sample, we extracted the reference and alternative allele depths from the VCF file 
and used their ratio as an estimate of the relative copy numbers of DEFA1 and DEFA3 (Fig. 1).
Haplotype determination by fiberfiSH. We used FiberFISH (fluorescence in-situ hybridisation) to 
obtain exact quantification of DEFA1A3 copy numbers (full details in supplementary materials). In brief, we 
produced a probe design (Figs. 1 and S1) and then generated the FiberFISH probe amplicons with the Qiagen 
LongRange PCR Kit (QIAGEN, Hilden, Germany) followed by shipment to Genomic Vision (Paris, France) for 
addition of fluorophores (Table S2). We selected four samples with high HTS CN and obtained their B lympho-
blastoid cell lines from the NHGRI Repository at the Coriell Institute of Medical Research (HG02554, HG02067, 
GM19320, GM18533). We then generated cell plugs that were shipped to Genomic Vision (Paris, France) for 
molecular combing on vinyl-silane treated coverslips followed by fluorescent probe hybridisation and imaging.
Copy number estimation by quantitative PCR (qPCR). 69 samples were selected for qPCR verification 
of the HTS-based CN estimates in such a way that all CN levels were well represented. This meant that almost 
all available samples with high HTS CN were selected whereas only a small fraction of available samples were 
selected at low CN (Table S3). DNA samples were obtained from the NHGRI Repository at the Coriell Institute 
of Medical Research (Camden, NJ, USA).
To determine the copy numbers of the DEFA1 and DEFA3 genes, we used the primer sequences proposed by 
Linzmeier and Ganz22. This involved using four sets of primers (Table S4). The DEFA1 and DEFA3 genes differ by 
one nucleotide only, so to discriminate between them, allele-specific primers were used. The last nucleotide of the 
forward (plus strand) primers covers the differing nucleotide, and the third to last nucleotide contains a mismatch 
to increase specificity of hybridization further (Fig. 1). The reverse primer was common for both DEFA1 and 
DEFA3. In addition to the allele-specific primers, a third primer set was also used, that amplifies both DEFA1 and 
DEFA3. The myeloperoxidase gene, MPO, was used as the endogenous control gene and the PCR reactions were 
run as described in the supplementary materials.
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We also obtained the 24 DNA samples that were originally genotyped by Linzmaier and Ganz from the Coriell 
Institute of Medical Research (Polymorphism Discovery Resource panel of 24 - M24PDR) and performed qPCR 
as for the 69 G1K samples.
Theoretically, if the efficiencies of the DEFAx amplifications and the endogenous control are both 100%, we 
can use the standard qPCR normalisation methods32 to compute the relative amount of DEFAx and endogenous 
control −2(C C )t,MPO t,DEFA  and this number can be scaled by 2 to obtain the number of DEFAx copies per diploid 
genome. For DEFA1A3, this approach is approximately correct. However, for DEFA1 and DEFA3, although we 
obtain estimates that are proportional to the true copy numbers, the absolute levels are incorrect. We therefore use 
the exact FiberFISH copy numbers for sample HG02554 to compute scaling factors for each of the primer sets 
using the following formula:
−FF /2DEFAx




where the superscript indicates the sample and FF is the copy number determined by FiberFISH (we estimate 
FFDEFA1
HG02554 and FFDEFA3
HG02554 by using the HTS estimate of the relative copy numbers of DEFA1 and DEFA3). This 
resulted in the following scaling factors for the different primer pairs: DEFA1: 3.319, DEFA3: 6.551, DEFA1A3: 
1.904. Note how the scaling factor for DEFA1A3 is close to 2 as it should be if the efficiency of the MPO and 
DEFA1A3 amplifications are both close to 100% whereas the scaling for DEFA1 and DEFA3 is much higher, indi-
cating that the efficiency of the DEFA1 and DEFA3 amplifications is much lower than that of MPO (which was to 
be expected due to the mismatch at the third to last nucleotide – Fig. 1).
neanderthal and Denisovan data. We obtained data on archaic humans by downloading the whole 
genome sequence data for the Denisova33 (http://cdna.eva.mpg.de/denisova/alignments/T_hg19_1000g.
bam), Altai34 (http://cdna.eva.mpg.de/neandertal/altai/AltaiNeandertal/bam/AltaiNea.hg19_1000g.8.dq.bam), 
and Vindija35 samples (http://cdna.eva.mpg.de/neandertal/Vindija/bam/Vi33.19.chr8.indel_realn.bam) and 
inspected these in the IGV browser36 for presence of DEFA1A3 copy number variation and DEFA3 variation.
Data availability
The raw data that support the findings of this study are openly available in the 1000 Genomes Project at https://
www.internationalgenome.org/ and the DNA and cell materials can be obtained from the Coriell Institute for 
Medical Research. HTS and qPCR data for the 69 samples and the FiberFISH data for the 4 samples has been 
deposited in dbVar (accession: nstd187).
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